Neumora Therapeutics, Inc. Common Stock (NMRA)

Typically moves ±7.09% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-09 APPROXIMATE

Since Nov 01, 2023, Neumora Therapeutics, Inc. Common Stock (NMRA) has reported earnings 12 times. On average the shares move ±7.09% post-earnings, with a positive reaction 50.0% of the time. Its largest post-earnings gain was +5.08% (Aug 06, 2025) and its largest decline was -17.2% (Mar 30, 2026). The next earnings report is predicted for 2026-11-09 (approximate).

Earnings reactions

How NMRA moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±7.09%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 14, 2026	☀ PRE	-7.47%	open_in_new
May 07, 2026	☀ PRE	-16.38%	open_in_new
Mar 30, 2026	☀ PRE	-17.2%	open_in_new
Nov 06, 2025	☀ PRE	-2.48%	open_in_new
Aug 06, 2025	☽ POST	+5.08%	open_in_new
May 12, 2025	☽ POST	+0.35%	open_in_new
Mar 03, 2025	☀ PRE	-9.62%	open_in_new
Nov 12, 2024	☀ PRE	-17.2%	open_in_new
Aug 06, 2024	☀ PRE	+0.33%	open_in_new
May 07, 2024	☀ PRE	+4.8%	open_in_new
Mar 07, 2024	☀ PRE	+2.93%	open_in_new
Nov 01, 2023	☽ POST	+1.25%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.09%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 18 →

Funds holding

$23322526

Total value held

Buying

12 added · 4 reduced

Blackrock, Inc.

$13246178 +279.29%

Johnson & Johnson

$3144057 Held

State Street Corp

$2689602 +296.80%

Northern Trust Corp

$1360971 +306.63%

Morgan Stanley

$543017 -36.60%

SEC Filing Types

description SCHEDULE 13G/A

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144	20260821	open_in_new SEC.gov
4	20260821	open_in_new SEC.gov
4	20260821	open_in_new SEC.gov
4	20260821	open_in_new SEC.gov
4	20260821	open_in_new SEC.gov
4	20260821	open_in_new SEC.gov
144	20260820	open_in_new SEC.gov
144	20260819	open_in_new SEC.gov
4	20260819	open_in_new SEC.gov
144	20260818	open_in_new SEC.gov

Frequently asked about NMRA earnings

When does Neumora Therapeutics, Inc. Common Stock report earnings next? expand_more

Neumora Therapeutics, Inc. Common Stock (NMRA)'s next earnings date is approximate for 2026-11-09. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does NMRA stock move after earnings? expand_more

Over 12 reports, NMRA has moved an average of ±7.09% the session after earnings, closing higher 50.0% of the time.

What was NMRA's biggest post-earnings move? expand_more

NMRA's largest post-earnings gain on record was +5.08% on Aug 06, 2025, and its largest decline was -17.2% on Mar 30, 2026.

Where can I find Neumora Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Neumora Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.